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SUMMARY 
Extracellular vesicles (EVs) are released by most cell types but providing evidence for their 
physiological relevance remains challenging due to a lack of appropriate model organisms. 
Here, we developed an in vivo model to study EV function by expressing CD63-pHluorin in 
zebrafish embryos. A combination of imaging methods and proteomic analysis allowed us to 
study biogenesis, composition, transfer, uptake and fate of individual endogenous EVs. We 
identified a subpopulation of EVs with exosome features, released in a syntenin-dependent 
manner from the Yolk Syncytial Layer into the blood circulation. These exosomes are 
captured, endocytosed and degraded by patrolling macrophages and endothelial cells in the 
Caudal Vein Plexus (CVP) in a scavenger receptor and dynamin-dependent manner. 
Interference with exosome biogenesis affected CVP growth, suggesting a role in trophic 
support. Altogether, our work represents a system for studying endogenous EV function in 
vivo with high spatio-temporal accuracy, demonstrating functional inter-organ 
communication by exosomes. 
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MAIN TEXT 
Extracellular vesicles (EVs) collectively include exosomes, 50-200nm diameter membranous 
vesicles secreted from multivesicular endosomes (MVEs) fusing with the plasma membrane 
(PM), and microvesicles (MVs), 50nm-1µm diameter membranous vesicles that bud from the 
PM. Exosomes and MVs are released by a wide variety of cell types and are found in all 
organism investigated so far (van Niel et al., 2018). Their implication in an increasing number 
of major physiological and pathological processes supports their putative role as essential 
intercellular messengers (Lo Cicero et al., 2015; Tkach and Théry, 2016). Most of the data on 
the function of EVs such as exosomes, however, is gathered from transformed cancer cells 
and relies on the use of a heterogeneous population of EVs purified from cell culture 
supernatant or liquid biopsies. Consequently, the propagation of endogenous exosomes in 
vivo is largely unknown and data on their biogenesis and role in normal developing tissue and 
adult tissue homeostasis distinctly lags behind. Understanding EV biogenesis, transfer and 
fate in recipient cells, however, is of prime importance not only from a fundamental point of 
view, but also to assess their relevance in pathological conditions as well as their use as 
therapeutic delivery systems (Fais et al., 2016). This apparent hiatus is largely due to the 
shortage of suitable models to visualize and track single endogenous EVs, and in particular 
exosomes in vivo from their site of production to their final destination in target cells (Hyenne 
and Goetz, 2017). Previous studies visualizing EV release and transfer have been limited to 
the detection of larger extracellular structures or their transfer from transplanted transformed 
cells (Lai et al., 2015; Zomer et al., 2015). 
Our main aim was to develop an integrated model to study EV release, transfer and function, 
which combines in vivo imaging with sub-cellular resolution while retaining the in toto 
imaging scale. Due to their small size and transparency, zebrafish embryos elegantly match 
the single-cell precision of C. elegans research in a vertebrate system with relevant 
architectural homology with mice and human. We show here that zebrafish embryos can be 
used to track exosomes in vivo by expression of the CD63-pHluorin reporter. This fluorescent 
reporter is specifically targeted to (late-) endosomes and secreted on exosomes, allowing live 
visualisation of exosome release in single cells in vitro (Verweij et al., 2018). Expression of 
CD63-pHluorin in zebrafish embryos revealed massive release of exosomes from the Yolk 
Syncytial Layer (YSL) into the blood flow that could be tracked in vivo throughout the animal 
up to their final destination. These exosomes are arrested and taken up by macrophages and 
endothelial cells of the caudal vein plexus (CVP) in a dynamin-dependent manner for 
degradation in lysosomes. Interference with syntenin-dependent exosome biogenesis in the 
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YSL affected CVP growth, supporting a trophic role of these exosomes. Altogether, these 
data reveal for the first time the secretion, journey and the uptake in target cells of individual 
endogenous exosomes secreted in vivo, and key molecular mediators of these processes. 
 
RESULTS  
Zebrafish cells secrete EVs containing exosomal proteins 
To investigate whether zebrafish could serve as a relevant model to study exosomes, 
we first assessed the presence of EVs in zebrafish embryos 3 days post fertilization (3dpf) by 
electron microscopy (EM). EM analysis revealed the presence of 100-200nm diameter 
vesicles clustered and enwrapped or free in the extracellular space (Fig 1A). We also 
processed the cell-culture supernatant of the zebrafish fibroblast AB.9 cell line with a 
differential ultra-centrifugation protocol (Théry et al., 2006). By electron microscopy we 
detected various vesicles in the size range of exosomes (~100nm) (Fig 1B). Proteomic 
analysis on the same preparations identified a variety of zebrafish homologues proteins 
traditionally found in mammalian exosomes, including tetraspanins CD63, CD9, CD82, and 
several heat-shock proteins (HSPs), including HSP70 and HSP90 (Fig 1C, Suppl. table I) 
and similar to the markers identified in exosomes derived from Zmel cells, a zebrafish 
melanoma cell line (Hyenne et al., co-submitted). This demonstrates that zebrafish cells 
release EVs that are enriched in the CD63 zebrafish ortholog, and supports the application in 
zebrafish of a fluorescent reporter that we recently used to visualize the fusion of 
multivesicular endosomes (MVE) with the plasma membrane (PM) in vitro, hCD63-pHluorin 
(Verweij et al., 2018). Due to its pH-sensitivity, CD63-pHluorin primarily reports its 
‘extracellular pool’ (i.e. PM and EVs) but obscures CD63 large intracellular pool present in 
acidic endosomal compartments (Sung et al., 2015). Injection of ubi:hCD63-pHluorin 
plasmid-DNA (pDNA) at the single-cell stage of Casper zebrafish embryos resulted in 
mosaic, transient expression of CD63-pHluorin in multiple cell types, including epithelial, 
endothelial, neuronal, red-blood- and muscle cells without obvious developmental defect of 
the embryo (Fig 1D-E). CD63-pHluorin associated fluorescence was localized at the PM of 
these cell types and to small, dotty structures potentially corresponding to CD63-pHluorin 
positive released EVs (Fig 1E, arrows). As previously shown in cell lines (Verweij et al., 
2018), we could detect MVE-PM fusion events (Fig 1F, box 2-3) in vivo, which were pretty 
rare (~1 every 10 minutes) but with similar  duration when compared to our observation in 
various cell lines in vitro (i.e. 20-30 sec) (Verweij et al., 2018). Current technical limitation of 
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imaging restricted the detection of MVE-PM fusion events in vivo to flat, stretched cells close 
to the dermis such as long-stretched fibroblast-like cell types (Fig 1F).  
 
A major pool of CD63 positive EVs is present in the bloodstream of zebrafish embryos 
One of the postulated assets of EVs is their potential as extracellular carrier in long-
range communication in vivo by entering the circulation (Thomou et al., 2017; Tkach and 
Théry, 2016). Despite circumstantial evidence, this has never been studied directly in a 
relevant physiological in vivo model. In zebrafish embryos, the cardio-vascular system 
develops with a heart-beat and a first transient wave of erythrocytes as early as at 24 hours 
post fertilization (Hermkens et al., 2015). Strikingly, in 3dpf zebrafish larvae expressing 
CD63-pHluorin, we could detect a large pool of CD63-pHluorin positive membranous 
structures carried by the blood flow in different parts of the vasculature throughout the body, 
including the brain and the gills (Fig 2A-B; Suppl. Movie 1). EM analysis on blood vessels 
of ubi:CD63-pHluorin plasmid (p)DNA expressing embryos confirmed the presence of 
numerous single EVs in the size range of exosomes (~100nm), but also a minor fraction of 
trapped vesicles and multivesicular structures that labelled positive for immunogold 
associated to anti-GFP antibody (Fig 2C-E). While the initial observations were done on 3dpf 
embryos, we could detect CD63 positive EVs as early as 24h (1dpf), at the onset of the blood 
flow (data not shown). This observation opened the opportunity to track individual 
endogenous EVs in vivo. 
 
The yolk syncytial layer (YSL) releases CD63-pHluorin positive exosomes in the 
bloodstream  
Next, we aimed to identify the cellular origin of the CD63 positive EVs detected in the 
bloodstream. The large surface area of the yolk syncytial layer (YSL), its highly differentiated 
secretory apparatus, high lysosomal activity, and cytoplasmic multivesicular structures by 
electron microscopy (Walzer and Schönenberger, 1979) made a plausible candidate for the 
vast number of EVs detected in the blood flow. Moreover, until the Duct of Cuvier closes at 
day 2.5, then forming the common cardinal vein, the YSL is in direct contact with the blood 
flow (Helker et al., 2013). Video-enhanced Nomarski microscopy revealed numerous EVs in 
the large interstitial space between the YSL and the overlying epidermis, at and even before 
the onset of blood circulation (Supp Fig 1A). Injection of ubi:CD63-pHluorin pDNA directly 
in the YSL at the 1000-cell stage (4hpf) (Supp Fig 1B) allowed for tissue-specific expression 
of CD63-pHluorin and circumvents the need for tissue specific promoters (Fig 3A). Immuno-
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gold labelling for GFP on thin cryo-sections of YSL CD63-pHluorin expressing 3dpf 
zebrafish embryos showed a massive number of vesicles ranging from 80-200nm in size 
immediately above the YSL and in direct contact with the blood (Fig 3B-C and Supp Fig 
1C). Consistently, CD63-pHluorin positive EVs were detected in the blood flow after tissue 
specific expression of CD63-pHluorin in the YSL (Suppl. Movie 2), and EM analysis of the 
blood vessels confirmed the nature of the fluorescent structures as single vesicles enriched in 
CD63-pHluorin in the size range of exosomes (~100-150nm) (Fig 3D). Moreover, YSL 
derived EVs that were observed in the blood flow accumulated in the caudal vein plexus 
(CVP) only in embryos with a detectable bloodstream (Fig 3E). This indicates that YSL-
derived EVs enriched in CD63-pHluorin are continuously released in the blood flow and can 
circulate through the entire embryo to reach their remote destination.  
Next, we characterized the nature of these fluorescent EVs by dissociating 3dpf CD63-
pHluorin YSL expressing and non-expressing control embryos using Collagenase I treatment, 
and isolating EVs from the supernatant with a differential ultra-centrifugation protocol (Théry 
et al., 2006). Immunogold labelling followed by electron microscopy observation of the 
CD63-pHluorin YSL expressing embryos derived pellet (Supp Fig 1C) confirmed the 
presence of vesicles heavily labelled for CD63-pHluorin with a morphology and a size (80-
120nm) comparable to those observed by EM in situ (Fig 3D). Whereas larger EVs were 
visible in the pellets, less than 5% of the labelled vesicles was larger than 150nm in size 
(Supp Fig 1C,D). Nanoparticle tracking analysis (Supp Fig 1E) of the 100 000g pellet of 
both conditions did not show significant differences in terms of size and number, suggesting 
that the expression of CD63-pHluorin in the YSL did not profoundly affect the release of EVs 
compared to basal condition. Pellets from both conditions were then further processed by 
immunoprecipitation against GFP using GFP-Trap agarose beads, followed by quantitative 
label-free proteomics analysis of the pull-down fraction. We quantified enrichment of specific 
proteins using non-injected zebrafish derived EV pellet as background. The most enriched 
proteins were Syntenin-a, TSG101, Rab7, ADAM10 and V1 ATPase subunit B2 that were 
only detected in the injected YSL EV-fraction and Alix (34x). Other YSL EV-enriched 
proteins included CMHP4c, EHD1, Cation-Independent Mannose 6-phosphate Receptor, 
Flotillin 1, CD63, CD82, the lysosomal acetyltransferase HGSNAT and the lysosomal amino 
acid transporter PQLC2. (Fig 3F, Supp Table II). Of note, several of the enriched proteins 
are implicated in one of the machineries involved in exosome biogenesis in endosomes in 
vitro (Baietti et al., 2012). These data strongly support an endosomal origin of YSL-derived 
EVs. This conclusion was reinforced by the presence of large MVEs that contain CD63-
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pHluorin positive ILVs (Fig 3G) in the YSL. Thus, CD63-pHluorin positive YSL-EVs 
present all the characteristics of endosome-derived exosomes as previously defined (Gould 
and Raposo, 2013). Finally, these YSL-exosomes were enriched for Molecular function GO 
terms “Anion binding”, “Small molecule binding” and ‘Transporter activity’, the latter being 
characterized by the presence of several Solute Carrier Family proteins, including zinc and 
amino acid transporters slc30a1a and slc3a2b. YSL derived exosomes displayed similarities 
with the composition of the AB.9 caudal fibroblast derived exosomes and to a certain extent 
with Zmel zebrafish cell line derived EVs (Supp Table I; (Hyenne et al., co-submitted)), as 
they both contain major actors of exosome biogenesis (Alix, TSG101, Chmp4C, tetraspanins). 
Nevertheless, physiological (this study) and pathological (Hyenne et al., co-submitted) 
exosomes differed by their composition that could be linked to their respective 
(patho)physiology (Supp Table II). Altogether, these data strongly suggest that expression of 
CD63-pHluorin in the YSL reveals the release of exosomes in the bloodstream of developing 
embryos. 
 
YSL-derived CD63 positive exosomes adhere to endothelial cells of the caudal plexus 
and are actively endocytosed by patrolling macrophages 
Having determined a cell layer of origin and transportation route of CD63 positive 
exosomes, we live-tracked them in the blood vasculature to identify potential target cells. Our 
data revealed an accumulation of dotty signals (Fig 3A) likely corresponding to immobilized 
exosomes in the blood, in particular in the caudal part of the vasculature. This area comprises 
the caudal artery (CA), and a complex, venous vascular network in between and originating 
from the cardinal vein (CV), called the caudal vein plexus (CVP) (Fig 4A).  
A maximum projection time-lapse movie of this region at higher magnification 
suggested an interaction between the labelled exosomes and the vessel wall (Fig 4A, Supp 
Movie 3A). Indeed, high-speed imaging of the cardinal vein confirmed the transient 
interaction of exosomes passing through the blood vessels with the plasma membrane of 
endothelial cells (Fig 4B, Supp Movie 3B). To visualize the extent and the exact localization 
of exosomes that adhere in the caudal part of the vasculature, we created a heat-map overlay 
of 6 individual YSL CD63-pHluorin pDNA injected embryos 3dpf (Fig 4C). Strikingly, the 
vast majority of exosomes was selectively arrested in the venous plexus and the caudal vein, 
but not in the caudal artery. This behaviour is remarkably similar to what was observed for 
intravenously injected Zmel1 EVs (Hyenne et al., co-submitted), suggesting a common 
behaviour for EVs of distinct origin and labelled with different tags in the blood flow of 
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zebrafish embryos. In high-magnification images we identified motile cells that crawled on 
the surface of the endothelial vessels and that contained labelled exosomes in intracellular 
compartments, likely resulting from their endocytosis (Fig 4D). Apart from endothelial cells, 
the lumen of the caudal vein plexus hosts a number of embryonic macrophages that 
continuously scavenge their environment and stand out by their relative high motility 
(Murayama et al., 2006). In Tg(kdrl:HRAS-mCherry) zebrafish embryos, these macrophages 
can be distinguished by their mCherry-positive compartments, probably as a result of 
endocytosis of (apoptotic) fragments of mCherry-expressing endothelial cells. By exploiting a 
Tg(mpeg1:mCherryF) fish line that specifically labels macrophages in red, we could identify 
these exosome internalizing cells as patrolling macrophages (Fig4E, Supp Movie 4A). 
Subsequent time-lapse imaging of macrophages in the caudal plexus of Tg(kdrl:HRAS-
mCherry) fish expressing CD63-pHluorin in the YSL revealed an active form of uptake of 
exosomes by macrophages that projected dendrites or pseudopodia, able to interact and 
‘harvest’ exosomes from the surface of endothelial cells (Fig 4F; Supp Movie 4B). Similar 
‘harvesting’ by patrolling macrophages was also observed for melanoma-derived exogenous 
EVs (Hyenne et al., co-submitted), suggesting common mechanisms for uptake of EVs of 
distinct origin.  
To further investigate the specificity of the uptake of labelled exosomes by 
macrophages of the CVP, we injected the yolk of CD63-pHluorin YSL expressing Casper 
embryos at 1dpf with 1.5 ng/nl BODIPY-C12 to specifically label the high amount of VLDL 
particles produced by the YSL and released in the blood flow, and to visualize the lumen of 
the blood vessels (Miyares et al., 2014). The BODIPY fluorescence was readily visible in the 
vasculature but was not overlapping with CD63-pHluorin labelling in the blood flow, 
confirming the nature of CD63-pHluorin positive EV as exosomes and not as derivatives of 
VLDL. Moreover, we did not observe any BODIPY signal in macrophages, while exosomes 
were again actively endocytosed (Fig 4G; supp Movie 4C). We did not observe an early 
decrease in fluorescence signal of CD63-pHluorin early (~3 minutes) after uptake (Fig 4G), 
in line with the observation of a large number of exosomes in the lumen of macrophages (Fig 
4E-F), suggesting temporal “storage” and/or a delayed targeting to acidic endosomal 
compartments. Altogether, these data revealed a specific uptake of exosomes by macrophages 
in intracellular compartments that become acidic at later time point and/or that initially 
maintain connection with the cellular exterior.  
 
YSL-exosomes are taken up and degraded by endothelial cells 
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The specific interaction of labelled exosomes with the venous - (Supp Movie 3) but not the 
arterial vasculature (Fig 4C), suggested potential implication of different shear forces exerted 
on EVs (Hyenne et al., co-submitted) between the venous and arterial blood flows. Drug 
treatment decreasing pacemaker activity (Vermot et al., 2009), and consequently the shear-
force of the blood flow, did not lead to a visible increase of the association of exosomes with 
the caudal artery (Supp Fig 1F). This indicates the implication of additional factors, such as 
expression of adhesion molecules, in this interaction. 
We further analysed the dynamic of interaction between exosomes and the 
endothelium by using high-speed imaging of the caudal vein of YSL CD63-pHluorin pDNA 
injected embryos 3dpf. We observed rolling, arrest and accumulation of exosomes on the 
endothelial wall of the vein (Fig 5A, Sup Movie 5A). Quantification of the duration of the 
interaction between exosomes and the venous vessel wall indicated that exosomes stay 
attached for an average duration of 3 min (Fig 5B). This behaviour is similar to that of 
exogenous melanoma-derived EVs (Hyenne et al., co-submitted) and reinforced potential 
molecular interactions between exosomes and specific receptors at the surface of venous 
endothelial cells. 
We observed that exosomes interacted transiently with endothelial cells and then 
disappeared (Fig 5B, Supp Movie 3, 5A), suggesting either their uptake by endothelial cells 
and targeting to acidic endosomal compartments, their re-entry into the blood flow or their 
dispersion outside of the vasculature. EM analysis of YSL CD63-pHluorin pDNA injected 
zebrafish revealed, qualitatively, that the former occurs, as we observed clusters of YSL 
derived exosomes immunogold labelled for GFP, and mixed with dense aggregates in endo-
lysosomal structures in endothelial cells of the caudal plexus (Fig 5C). This suggested a 
degradative fate of exosomes that we further investigated by treating zebrafish embryos with 
a specific inhibitor of the vacuolar H(+)-ATPase, Bafilomycin A1 (BafA), that elevates 
endosomal pH and decreases lysosomal degradation (Christensen et al., 2002). Strikingly, 
incubation for 2h with 100nm BafA showed that, consistent with sites of exosomes-
endothelium interaction (Fig 4C), endothelial cells of the vein plexus and cardinal vein but 
not the caudal artery endocytosed considerable amounts of CD63-pHluorin exosomes over 
time, mostly concentrating at peri-nuclear areas (Fig 5D, nuclei indicated with (N)). This 
accumulation, after only two hours of treatment, suggests that exosomes are mainly and 
continuously taken up by endothelial cells to be degraded in acidic endo-lysosomes.  
We then tested whether exosomes could propagate beyond vascular endothelial walls. 
For this, we imaged the area of the caudal vein plexus and clearly observed labelled exosomes 
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outside of the posterior cardinal vein (PCV) (Fig 5E, F; Suppl Movie 5B). Even though we 
observed some of the larger fluorescent exosome clusters concentrated adjacent to the CVP, 
we detected high levels of fluorescent exosomes outside of the vasculature throughout the 
whole embryo, notably visible where covering the muscle segments and flowing in the neural 
tube (Suppl Movies 5B-C). The motility of the exosomes we observed outside the 
vasculature was irregular and resembled Brownian motion, clearly distinct from the dynamics 
of intracellular endosomal transport (Suppl Movie 5B). However, in muscle cells, 
Bafilomycin A treatment (Supp Movie 5D) did not show accumulation of YSL derived 
exosomes as observed for endothelial cells. The large majority of endocytosed exosomes was 
thus observed in endothelial cells and to a lesser extent in patrolling macrophages but not in 
other cell types, highlighting the specificity for targeted cells.  
 
Uptake of YSL-derived exosomes by endothelial cells relies on scavenger receptors and 
dynamin-dependent endocytosis 
This specific interaction of exosomes with target cell types likely relied on specific 
receptors (van Niel et al., 2018). The visualization of internalized CD63-pHluorin exosomes 
with BafA treatment, allowed us to interfere with general uptake mechanisms by inhibiting 
dynamin, a key regulator of clathrin dependent and independent endocytosis (Ferguson and 
De Camilli, 2012). We treated 2dpf YSL CD63-pHluorin expressing Tg(kdrl:HRAS-mCherry) 
embryos, expressing mCherry in the vasculature, with 3µM of dynamin inhibitor Pyrimidyn-7 
prior to BafA treatment. Strikingly, we observed a near complete block of exosome uptake by 
endothelial cells (Fig 6A), excluding the uptake mechanisms of exosomes via dynamin 
independent pathways and possibly macropinocytosis (Harper et al., 2013). Mander’s 
coefficient (M2) of the green signal (exosomes) overlapping with the red signal (endothelium) 
revealed an average decrease of more than 10-fold of the uptake (Fig 6B). Comparison of 
Mander’s coefficient after 180-degress rotation excluded potential interference of random 
overlap (Sup Fig 1G). Similar quantification in ctrl or Pyrimidyn-7 condition showed a 5-fold 
reduction of uptake in macrophages (Fig 6C).  
To assess the efficiency of exosome uptake, we performed 4D imaging of the Cardinal Vein 
(CV) of 3dpf YSL CD63-pHluorin expressing Tg(kdrl:HRAS-mCherry) embryos treated with 
100nM BafA. Time-lapse imaging indicated that exosomes accumulated over the ~1h time-
coursed imaged (Supp Movie 6A), whereas a z-stack and a 3D rendering of the same z-stack 
showed a substantial presence of internalized exosomes per cell (Supp Movie 6B). Similar 
findings were obtained at 2dpf (data not shown). Together, this indicates that exosome uptake 
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by the ECs of the CVP is not a sporadic event, but occurs in a continuous fashion. We next 
focused on potential receptors able to specify this endocytosis to endothelial cells. 
Interestingly, the CVP area harbors scavenger endothelial cells (SECs) that interact in 
a scavenger-receptor mediated manner with liposomes of 100nm injected in the circulation 
(Campbell et al., 2018). Scavenger receptors have been also reported in vitro to mediate 
exosome uptake (Plebanek et al., 2015) and are expressed on endothelial cells and 
macrophages and is conserved in teleost (Poynter et al., 2015) and mediate dynamin-
dependent endocytocis (Jang et al., 2014). To investigate whether scavenger receptors are 
implicated in exosome uptake in vivo, we injected dextran sulfate (DexSO4-500K), a known 
competitive ligand for scavenger receptors (Lysko et al., 1999), intravenously in CD63-
pHluorin YSL expressing Tg(kdrl:HRAS-mCherry) embryos prior to BafA treatment. 
Strikingly, we observed a decrease of more than 4-fold of the green signal (EVs) overlapping 
with the red signal (endothelium) (Fig 6D-E), indicating that endogenous exosomes competed 
with DexSO4-500K for their uptake by the same class of receptors. We did not observe a 
significant decrease in uptake in macrophages (Sup Fig 1H).  
This set of data revealed that in vivo, endogenous exosomes are specifically 
internalized by specialized veinous endothelial cells in a dynamin- and scavenger receptor 
dependent pathway to be targeted to lysosomes for degradation. 
 
Production of YSL-derived exosomes relies on a syntenin-dependent biogenesis pathway 
and supports vasculogenesis of the caudal vein plexus 
The enrichment for a Syntenin–Alix mediated machinery in YSL-exosomes (Fig 3F) 
led us to interfere with their generation and further investigate their potential function in vivo. 
A previous study in zebrafish reported the expression of syntenin-a, notably in YSL, at 
different stages of development (Lambaerts et al., 2012). Depletion of syntenin-a in the whole 
embryo in the same study revealed defects in epiboly progression and body-axis formation 
during early zebrafish development whereas depleting syntenin-a solely in the YSL only 
affected epiboly in 30% of the embryos and resulted in a well-formed axis in all embryos. We 
co-injected one of these morpholino oligonucleotides, validated in conformity to recently 
published guidelines (Stainier et al., 2017), targeting the translation start site in syntenin-a 
transcripts (SyntA MO), or control morpholino (Ctrl MO) together with CD63-pHluorin 
pDNA specifically in the YSL of Tg(kdrl:HRAS-mCherry) embryos 4hpf. Of note, in our 
experiments most embryos displayed normal development but showed a small delay in 
hatching and increase in mortality (Fig 7A-C). When considering only embryos with normal 
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development (>50% in both conditions), whole body analysis showed expression of CD63-
pHluorin in the YSL (Fig 7A) but a profoundly diminished number of fluorescent exosomes 
in the blood flow for the SyntA MO compared to the Ctrl MO condition (Fig 7D,E) that could 
be rescued by co-injection of MO-insensitive wtSyntenin-A plasmid DNA (Sup Fig 2A,B). 
This suggests that syntenin is implicated in CD63 positive exosome biogenesis in the YSL in 
vivo and that endogenous exosome biogenesis can be manipulated. Incubation of these 
embryos for 2h with 100nm BafA confirmed the near absence of exosomes in the CVP, 
corresponding with a 20-fold reduction of the uptake of exosomes by endothelial cells in this 
region (Fig 7F). While we did not observe any major defect in angiogenesis or growth of 
SyntA MO embryos at 3dpf (Fig 7C), we did observe a decrease of ~18% in the height of the 
CVP between SyntA MO and Ctrl MO treated embryos (Fig 7G-H), suggesting a role of 
exosomes produced from the YSL in the development of the CVP by taking them up and 
targeting them to lysosomes. Finally, we aimed to further assess the effect of YSL-exosome 
depletion on CVP growth. For this, we performed imaging of YSL SyntA MO and Ctrl MO 
injected embryos over time between 35-40hpf and quantified the number of nuclei and the 
expansion of the vascular bed (Fig 7I-M). While the nuclear density was comparable, the 
growth of the CVP as well as the cell proliferation was lower in SyntA MO YSL-injected 
compared to Ctrl MO YSL-injected embryos (Fig 7I-K), whereas cellular motility seemed 
unaffected. Together, this indicates that YSL exosomes support CVP growth, mainly by 
affecting cell proliferation.  
Collectively, these data demonstrate that endogenous biogenesis of exosomes can be 
modulated, revealing physiological effects in defined target cells.  
 
DISCUSSION 
Until now, the development of a model to explore the release, journey and targets of 
endogenous exosomes in vivo had been hampered by the small size of the exosomes and the 
lack of appropriate methods to label them. A recent study reported the use of CD63-GFP in 
transgenic rats (Yoshimura et al., 2016) that demonstrated its usefulness for the ex vivo 
analysis of EV transfer to organs and bodily fluids but that was limited in its suitability for in 
vivo imaging. Here, we sought to fill that void by exploring a vertebrate model suitable for in 
toto imaging while maintaining sub-cellular and even supra-optical resolution. The CD63-
pHluorin strategy has been recently shown to be an accurate in vitro model to explore new 
facets of the molecular mechanisms that control the biogenesis and secretion of exosomes 
(Verweij et al., 2018). Our study demonstrates that the CD63-pHluorin reporter can be used in 
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vivo to investigate the molecular regulation of exosome secretion. This approach, however, is 
currently still limited by a technological latch that hinders quantitative observation of bursts 
of fluorescence in cells that are not flat. In our model, we observed a relatively limited 
number of fusion events compared to transformed cell lines in vitro, which is in line with in 
vitro experiments indicating lower fusion activity for non-transformed cells (Verweij et al., 
2018) as well as increased presence of exosomes in bodily fluids of cancer patients (Galindo-
Hernandez et al., 2013; Logozzi et al., 2009). Interestingly, the transposition of this tool in 
vivo also provided a model allowing single vesicle tracking from their site of production to 
their final destination, and might be useful to investigate the dynamics of body fluid flows 
with high precision (Bachy et al., 2008). 
We observed a large number of fluorescent vesicles in the blood after ubiquituous 
expression of CD63-pHluorin. IEM labelling confirmed that CD63-pHluorin was associated 
to vesicular structures (Sup Fig 1C, 2D). Using tissue-specific expression, we could trace the 
origin of these exosomes, and identified the Yolk Syncytial Layer (YSL), a secretory cell 
layer in direct contact with the blood, as one of the providers of endogenous exosomes that 
reach the rest of the organism. Mass spectrometry analysis of EVs derived from cell lines 
(AB.9, Zmel) and embryos in our study and in (Hyenne et al., co-submitted) showed a 
common composition and highlights a consistent presence of proteins involved in exosome 
biogenesis by the syntenin-Alix-ESCRT-III pathway, previously reported in vitro (Baietti et 
al., 2012). Our data strongly suggest that the EVs followed in this study are likely of 
endosomal origin, although we cannot exclude the contribution of the plasma membrane of 
the YSL as source of EVs. Of note, treatment of embryos with GW4869 did not affect 
exosome release from the YSL (Supp Fig 2E), suggesting that at least for this source of 
exosomes, ceramide is not a major regulator of their biogenesis (Trajkovic et al., 2008). These 
data suggest that in vivo, the syntenin-Alix-ESCRT-III pathway is among one of the essential 
pathways for exosome biogenesis, opening avenues to interfere with EV generation and 
function in vivo.  
Our initial explorations uncovered endothelial cells and patrolling macrophages as 
recipient cells, strengthening the notion of targeted communication by exosomes. Although 
we cannot exclude a specific role of YSL derived exosomes once taken up by macrophages, 
these scavenger cells may harvest exosomes dwelling at the surface of endothelial cells to 
regulate the steady state level of EVs in the circulation (Imai et al., 2015). However, we also 
observed that the internalizing compartments containing EVs 1) do not immediately acidify 
(Fig 4G), and 2) might be internalized slower, as we did not need to use Bafilomycin A 
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treatment to visualize uptake in macrophages and still observed green EVs in macrophages 
after prolonged incubation with DS500K (Supp Fig 1H). This would be compatible with a 
functional interaction between the EVs and the macrophage, recently demonstrated in a 
cancer setting (Gabrusiewicz et al., 2018), and might be part of an immune surveillance 
function analogous to Kupffer cells (Jenne and Kubes, 2013). In zebrafish, we show that 
endogenous exosomes are mainly targeted to the veinous endothelial cells of the CV(P). 
These cells show functional homology with specialized Liver Sinusoidal Endothelial Cells 
(LSECs) in higher vertebrates (Campbell et al., 2018), indicating inter-species correlation 
with the targeting of injected EVs to the liver in murine models (Charoenviriyakul et al., 
2017; Wiklander et al., 2015). LSECs clear soluble macromolecules and small particles from 
the circulation and in humans possess the highest endocytic capacity of all cells (Poisson et 
al., 2017). In older vertebrates, jawless, cartilaginous and bony fish, cells resembling the 
LSEC are located at different locations outside the liver and are collectively called Scavenger 
Endothelial Cells (SECs) that are similarly central to the removal and catabolism of a variety 
of macromolecules from the circulation (Seternes et al., 2002).  
We show that the uptake mechanisms of EVs by endothelial cells in the CV(P) implicate 
Scavenger Receptors and dynamin-dependent endocytosis. Indeed, various scavenger 
receptors internalize their ligands in a dynamin-dependent manner and traffic to lysosomes 
(Fukuda et al., 2011). Scavenger receptors, such as Stabilin-2, have been recently described as 
mediating the uptake of 100nm-sized anionic liposomes in zebrafish (Campbell et al., 2018). 
This suggests that exosomes, having a negative z-potential (due to the presence of anionic 
lipids), could bind in a similar fashion to these receptors, independently of a specific ligand 
present on the exosomal membrane.  
The lysosomal fate of YSL-derived exosomes in endothelial cells echoes data showing that 
uptake and catabolism of exosomes in lysosomal compartments is likely a major fate as 
described in vitro (Tian et al., 2010). This pathway would allow catabolism of EV content and 
provide a source of amino acids, nucleic acids, lipids and ions to recipient cells. Although we 
cannot rule out a structural function of YSL derived EVs during development, e.g. in 
patterning or differentiation (McGough and Vincent, 2016), the effect we observed on CV 
and CVP development when interfering with EVs biogenesis also suggests that endothelial 
cells may uptake and process EVs in lysosomes to use them as a source of macromolecules 
for their own development (Yao et al., 2017). It is also possible that these exosomes provide 
an extracellular source of membrane to allow for expansion of the vascular bed, analogues to 
the involvement of late-endo/lysosomes in protrusions and neurite outgrowth (Naegeli et al., 
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2017; Raiborg et al., 2015). In accordance with this, we observed a lower proliferation rate of 
CVP endothelial cells with reduced levels of CD63 exosomes coming from the YSL (Fig 7J). 
These data raise the possibility that uptake of exosomes by LSEC, beyond a simple removal 
role of exosomes from the circulation, indeed may support a trophic link between the YSL 
and LSCEs. 
The presence of numerous EVs in the bloodstream but also in the interstitial fluid 
(ISF) of developing zebrafish embryos strengthens ex-vivo observations of the presence of 
EVs in both fluids (Gromov et al., 2013; Johnstone et al., 1989). Recent evidence indicates 
that exosomes or EVs containing miRNAs can also in- and extravasate biological barriers to 
access in ISF under physiological conditions (Thomou et al., 2017) but the YSL in zebrafish 
is directly connected with the ISF, providing a direct way for exosomes from YSL to access 
the ISF. The motility of the CD63-pHluorin positive exosomes we observed outside the 
vasculature was irregular and resembled Brownian motion (Suppl Movie 5B), clearly distinct 
from the dynamics of intracellular endosomal transport. Of note, Bafilomycin A treatment (as 
in Fig 5D) did not show accumulation of YSL derived exosomes in other cells such as the 
highly abundant muscle cells (Suppl Movie 5D). These observations would exclude uptake 
and lysosomal degradation as a major way to use EVs as a source of macromolecules by other 
cells than endothelial cells. Of note, our proteomic analysis revealed the presence and 
enrichment for various lipid-, amino acid and ion transporters that could support a role of 
YSL-derived exosomes as ‘macromolecule dispenser’ to surrounding cells, as these 
transporters could potentially mediate the bioavailability of exosomal contents (Allen and 
Cullis, 2013). All in all, the presence of these EVs in various bodily fluids supports a general 
role in metabolism, e.g. in nutrient delivery, and makes a specific role in other YSL functions, 
e.g. embryonic patterning, less likely. Nevertheless, we cannot exclude that these EVs are 
used to exchange genetic information between cells in vivo as shown recently (Ashley et al., 
2018; Pastuzyn et al., 2018; Zomer et al., 2015) and future development of adapted tools as 
described in vitro (Yim et al., 2016) are required to explore these functions in detail.   
Despite its several advantages, we cannot exclude that in this model, expression of this 
reporter might affect exosome secretion or composition. Nevertheless, nanoparticle tracking 
did not show a significant change of the number of particles between non-injected and CD63-
pHluorin YSL expressing embryos, and proteomics indicated the presence of endogenous 
zCD63 in the YSL-CD63-pHluorin labelled exosomes. Another potential downside of our 
approach might be that expression of a TSPAN-reporter may only label a subpopulation of 
YSL-derived exosomes as CD63 may not be equally enriched in all exosome subpopulation 
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(Kowal et al., 2016). Larger (>150nm) vesicles, predominantly negative for CD63-pHluorin, 
suggest the presence of different sub-populations in our model. Isolating a subpopulation 
from the heterogenous family of EVs with this reporter present however the advantage to 
target specific fate or functions. Future studies using other TSPAN-pHluorin markers, 
including CD81, CD82, or CD9 (Verweij et al., 2018), could aid to cover the whole spectrum 
of EVs. The present study was restricted to the YSL, excluding from our observation all EVs 
released by other cell types that might represent up to 90% of the pelleted vesicles from 
dissociated fishes (Supp Figures 1C, 2D). Development of future strains with cell type 
specific expression will allow to investigate the various roles of exosomes secreted under 
physiological and pathological conditions by nearly all cell types investigated so far. In 
addition, combining cell-type specific expression of TSPAN-pHluorin markers with 
proteomic analysis of immuno-isolated exosomes could potentially be used to discover 
pathological bio-markers for each producing cell type targeted in vivo. What also might be 
considered as a drawback in some applications is that we use a pH-sensitive GFP, meaning 
that EVs that are taken up in recipient cells will in most cases likely end up in acidified 
compartments, resulting in quenching of their fluorescence. In this study, we do however 
show that bafilomycin treatment reverts this acidification and consequently quenching of 
fluorescent EVs and the addition of a pH-insensitive fluorescent label to CD63-pHluorin can 
also be considered. 
In this study we opted for the morpholino (MO) strategy to achieve a tissue specific 
knock-down of Syntenin-a in the YSL. Although generally targeted mutagenesis using 
CRISPR/Cas9 would be the method of choice, the generation of a null allele would not affect 
maternal contribution of syntenin-a mRNA (Lambaerts et al., 2012) until reaching F3, and 
maternal-zygotic mutants will likely have too broad effects to address our specific point. 
While we did initiate the generation of a null line (data not shown), we realized that since 
exosome secretion from the YSL could be observed as early as 1dpf, the use of MO injected 
in the YSL was preferred to 1) be able to affect maternal contribution of syntenin-a mRNA 
and 2) achieve tissue specific knock-down of Syntenin-a. We are well aware that the 
application of MO in zebrafish has to be approached with caution, and proper controls are 
needed to distinguish specific phenotypes from off-target effects, as outlined in recently 
published guidelines (Stainier et al., 2017). The specific MO we applied has been used in a 
previous publication and complies with the additional guidelines as recently set out 
(Lambaerts et al., 2012; Stainier et al., 2017). In addition, we titrated the MO for its ability to 
sufficiently block exosome secretion while minimizing mortality, and performed an additional 
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rescue experiment (Suppl Fig 2A). Future studies with Syntenin-a KO lines will be 
indispensable to deepen our understanding of the contribution of this exosome biogenesis 
pathway to exosome physiology in vivo, but might require tissue-specific KO. 
Importantly, the study of Hyenne et al (co-submitted) also used zebrafish embryos to 
investigate the behaviour and fate of systemically injected exogenous exosomes originating 
from zebrafish melanoma cells. Whereas previous studies have indicated how tumour-
exosome integrins determine their organotropism (Hoshino et al., 2015), the combination of 
both models presented here reveals common uptake mechanisms between 
exogenous/pathological exosomes and endogenous/physiological exosomes, an interesting 
phenotype that has never been explored before at this scale. How circulating EVs target 
specific cell types at distance remains to be solved, mostly because this step could not be 
visualized before, but the in vivo models presented here pave new avenues to unveil such 
mechanisms under physiological and pathological conditions. The genetic and structural 
homologies between zebrafish and human open new perspectives to validate exosome-
mediated intercellular communication in the complex architecture of the organism, notably 
inter-organ communication and their ability to cross biological barriers. The fast development 
of disease models in zebrafish also provides the opportunity to tackle putative roles of 
exosomes in several pathologies (Yáñez-Mó et al., 2015) that involves a complex network of 
cell types. Therefore, the zebrafish embryo expressing fluorescent proteins associated with 
exosomes (e.g. CD63-pHluorin) is a relevant model to study endogenous EVs in vivo, to 
unravel fundamental aspects in EV physiology and to assess their clinical applications. 
Together, our study showcases the variety of questions that could likely be investigated in 
model organisms to validate the numerous in vitro studies on the biology and function of EVs 
so far. 
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FIGURE LEGENDS  
Figure 1 | Identification and in vivo visualization of EVs in zebrafish (A) Electron 
microscopic analysis of a 3dpf zebrafish embryo showing heterogeneous EVs between basal 
epidermal cells. White arrows indicate exosome-like vesicles, black arrow indicates an 
enwrapped cluster of vesicles. (B) Electron microscopy observation of EVs purified by ultra-
centrifugation from the supernatant of AB.9 caudal fibroblast cells. (C) Mass-spectrometry 
analysis of AB.9-derived EVs (excerpt, complete list in sup Table I). (D) Transient mosaic 
expression of ubi:CD63-pHluorin in 35hpf zebrafish embryo, pseudo-coloured for depth. (E) 
Example of cell types in caudal fin targeted by transient mosaic expression of CD63-pHluorin 
(3dpf). Identified can be, among others, skin epithelial (SE), neuronal (N), fibroblast cells 
(FC). Arrows point at labelled EV. (F) Example of a fusion event observed in a fibroblast-like 
cell (1), with zoom in (2), and time-lapse heat map of the event (3). 
 
Figure 2 | EVs travel through the blood flow (A) Dorsal view of the vasculature in the head 
of a Tg(kdrl:Hsa.HRAS-mCherry) 3dpf zebrafish larva expressing CD63-pHluorin after 
injection of ubi:CD63-pHluorin pDNA at the 1-cell stage. Boxes I and II indicate areas of 
interest imaged for CD63-pHluorin, shown in (A) (lower panel) and (B). (B) Still of time-
lapse sequence shown in Sup Movie 1A, indicating the approximate vasculature wall (dashed 
white lines), a red blood cell (RBC), and in the dotted box a sample of EVs seen in the 
bloodstream, which is magnified in the insert. Arrows indicate the direction of the blood flow. 
(C) IEM on the vasculature of ubi:CD63-pHluorin pDNA injected fish (transient mosaic 
expression), labelled with gold particles directed to GFP (10 nm), showing (D) single- (upper 
panel) and clusters (lower panel) of vesicles, corresponding to the dotted boxes in (C). (E) 
Quantification of vesicle labelling and appearance (single/clustered) of EVs as in (C) (mean ± 
SD, >25 different fields, n = 2) 
 
Figure 3 | Origin and composition of exosomes in the blood flow (A) Fluorescence image 
of a 3dpf Tg(kdrl:Hsa.HRAS-mCherry) embryo injected with ubi:CD63-pHluorin in the YSL, 
green channel (top), red channel (middle) and merge (bottom). Box [EM] indicates the 
approximate region for EM analysis (shown in B-D). Box to the right indicates the area 
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shown in (E). (B) IEM image of the YSL of a 3dpf Tg(kdrl:Hsa.HRAS-mCherry) embryo 
injected with ubi:CD63-pHluorin in the YSL labelled with gold particles directed to GFP (10 
nm). Dashed white lines indicate the approximate membranes of the YSL. Dashed line box 
indicates area shown enlarged in (C). RBC = red blood cell. (C) Zoom in of area indicated in 
(B), showing MVE (asterisk) in the YSL, and EVs labelled for gold particles directed to GFP 
(10 nm) on top of the YSL. (D) (left panel) IEM image of exosome-sized EVs observed in 
blood vessel lumen, labelled with gold particles directed to GFP (10 nm). Graph on the right: 
quantification of vesicle labelling and appearance as in Fig 2E (mean ± SD, >25 different 
fields, n = 2). (E) Zoom in on area indicated with rectangular box on the right in (A). Left 
panel, fish with blood flow, right panel, fish without blood flow, both expressing CD63-
pHluorin in the YSL. (F) Mass-spectrometry analysis of enriched proteins in YSL-derived 
EVs (excerpt, complete list in sup Table II). (numbers between bracket indicated the rate of 
enrichement in injected embryos compared to control embryos, OI: only detected in injected 
embryos). (G) IEM image of an MVE in the YSL area, labelled with gold particles directed to 
GFP (10 nm). Thin dashed white circle indicates an MVE.  YSL = Yolk Syncytial Layer; 
MVE = Multi-Vesicular Body. 
 
Figure 4 | Distribution and target cells of YSL-exosomes (A) Still of time-lapse shown in 
Sup Movie 3A of the CVP of a 3dpf Tg(kdrl:Hsa.HRAS-mCherry) embryo expressing CD63-
pHluorin in the YSL. Dashed box indicates area shown at higher magnification to the right. 
(B) Average projection of 15 sequential frames of Sup Movie 3B, showing caudal artery 
(CA), CVP and the cardinal vein (CV) in 3dpf zebrafish embryos expressing CD63-pHluorin 
in the YSL. (C) Heat-map of CD63-pHluorin signal in CVP of 6 3dpf Tg(kdrl:Hsa.HRAS-
mCherry) zebrafish embryos expressing CD63-pHluorin in the YSL. (D) CVP of a 3dpf 
Tg(kdrl:Hsa.HRAS-mCherry) embryo expressing CD63-pHluorin in the YSL. Stars indicate 
macrophages. Dashed box indicates area shown in Sup Movie 4B and in (F). Asterisks 
indicate macrophages. (E) Still of Sup Movie 4A, showing the CVP of a 3dpf 
Tg(mpeg1:mCherryF) expressing CD63-pHluorin in the YSL. Asterisks indicate 
macrophages. (F) Time-lapse of a macrophage in a 3dpf Tg(kdrl:Hsa.HRAS-mCherry) 
zebrafish embryo expressing CD63-pHluorin in the YSL, shown in Sup Movie 4B. (G) Time-
lapse of a BODIPY-C12 injected macrophage in a 3dpf zebrafish embryo expressing CD63-
pHluorin in the YSL, shown in Sup Movie 4C. CA = caudal artery; YSL = Yolk Syncytial 
Layer; CVP = Caudal Vein Plexus.  
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Figure 5 | Interaction of YSL-exosomes with endothelium and presence of YSL-
exosomes in ISF (A) Time-lapse of Sup Movie 5A, showing the rolling and arrest of 
exosomes in the cardinal vein of 3dpf zebrafish embryo expressing CD63-pHluorin in the 
YSL. (B) Quantification of dwelling time of CD63-pHluorin exosomes at the vascular wall 
(mean ± SD, n = 20 events). (C) EM image of the CVP of a 3dpf zebrafish embryo expressing 
CD63-pHluorin in the YSL, labelled with gold particles directed to GFP (10 nm). Insert 
indicates area shown at higher magnification to the right. Arrow indicates internalized CD63-
pHluorin exosomes in endo-lyosomal compartment of endothelial cell. (D) Close-up of the 
cardinal vein of 3dpf Tg(kdrl:Hsa.HRAS-mCherry) zebrafish embryos expressing CD63-
pHluorin in the YSL, control treated (DMSO) or treated with BafilomcinA (BafA) to 
neutralize acidic compartments. (E) CVP area of 3dpf Tg(kdrl:Hsa.HRAS-mCherry) zebrafish 
embryos sham-injected or injected with CD63-pHluorin pDNA in the YSL. (F) Mid-trunk 
segment of 3dpf zebrafish embryos expressing CD63-pHluorin in the YSL and mCherry 
under the ubiquitous RPL5 promoter. At this exposure level in the red channel, mostly muscle 
cells are visible. YSL = Yolk Syncytial Layer; CVP = Caudal Vein Plexus. 
 
Figure 6 | Characterization of uptake mechanism YSL-exosomes by endothelial cells 
(A) Close-up of the CVP area of 3dpf Tg(kdrl:Hsa.HRAS-mCherry) zebrafish embryos 
expressing CD63-pHluorin in the YSL, treated with BafA to show internalized EVs and co-
treated with DMSO (CTRL) or dynamin-inhibitor Pyrimidyn-7 (Pyrimidin-7). (B) 
Quantification of experiments as performed in (A), showing the overlap-coefficient of red 
with green (M1) and green with red (M2) signal (mean ± SD, ****p ≤ 0.0001; n ≥ 3; unpaired 
t-test with equal SD). (C) As in (B), but for macrophages alone (mean ± SD, ****p ≤ 0.0001; 
7 macrophages per condition, n ≥ 3; unpaired t-test with equal SD). (D) Close-up of the CVP 
area of 3dpf Tg(kdrl:Hsa.HRAS-mCherry) zebrafish embryos expressing CD63-pHluorin in 
the YSL treated with BafA to show internalized exosomes and non-injected or injected with 
500K Dextran Sulfate (DS500K). (E) Quantification of experiments as performed in (D) 
(mean ± SD, *p ≤ 0.05; n ≥ 2; unpaired t-test with equal SD). YSL = Yolk Syncytial Layer; 
BafA = Bafilomycin A; CVP = Caudal Vein Plexus.  Scalebars indicate 10 µm. 
 
Figure 7 | Functional analysis of YSL-exosomes (A) Transmission and fluorescent images 
of Ctrl MO or SyntA MO treated 1dpf zebrafish embryos. (B) Quantification of 
morphological features of Ctrl MO or SyntA MO treated 1-3dpf (24h-72h) zebrafish embryos. 
To the left, hatched vs non-hatched comparison. To the right, health status comparison with 
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normal morphology (healthy), mild or severe developmental defects and mortality. Sample 
size ≥ 120. (C) Size (length) of Ctrl MO or SyntA MO treated 3dpf zebrafish embryos 
(scatter-dot plot, mean ± SD; n = 19, n = 18 resp). (D) Close-up of the CVP area of 3dpf 
Tg(kdrl:Hsa.HRAS-mCherry) zebrafish embryos expressing CD63-pHluorin in the YSL, co-
injected with with Ctrl MO or SyntA MO in the YSL. Left panel: frontal view; right panel: 
lateral view. CA = caudal artery, CV = cardinal vein. (E) Fluorescent intensity of GFP signal 
in CA measured during different treatments. BafA = Bafilomycin-A, Pyr = Pyrimidyn-7, 
DS500K= 500KDa Dextran Sulfate, SyntA MO=Syntenin-A Morpholino, A.U. = arbitrary 
units. mean ± SD; ****p ≤ 0.0001; all conditions show at least triplicates of n ≥ 3; unpaired t-
test with equal SD. (F) Quantification of overlap-coefficient of red with green (M1) and green 
with red (M2) in Ctrl MO or SyntA MO treated 3dpf Tg(kdrl:Hsa.HRAS-mCherry) zebrafish 
embryos (as shown in D) (mean ± SD; ****p ≤ 0.0001; n = 5; unpaired t-test with equal SD). 
(G) Quantification of height of caudal part of vasculature, specifically for the CVP at second 
intersegmental vessel (ISV), or (H) measured from CA to CV (scatter-dot plot, mean ± SD; 
*p ≤ 0.05; n ≥ 10, n ≥ 9 resp; unpaired t-test with equal SD). (I, J, K) Tg(kdrl:eGFP /nls-
mKate2) embryos injected with control (Ctrl MO) or Syntenin-a (SyntA MO) morpholinos in 
the YSL, analysed for growth (I), proliferation (J), and nuclear density (K) in the CVP 
between 35-40hpf (mean ± SD; *p ≤ 0.05; **p ≤ 0.01; n = 4; unpaired t-test with equal SD). 
(L) Time-lapse of Tg(kdrl:eGFP /nls-mKate2) embryos between 35-40hpf. Boxes indicate 2 
examples of proliferating cells (as shown in M). Scalebar indicates 40µm. (M) Two examples 
of dividing cells are shown. Scalebar indicates 15µm. YSL = Yolk Syncytial Layer; CVP = 
Caudal Vein Plexus. 
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Zebrafish strains 
Zebrafish were staged and cared for according to standard protocols (Westerfield). All fish are 
housed in the fish facility of our laboratory, which was built according to the local animal 
welfare standards. All animal procedures were performed in accordance with French and 
European Union animal welfare guidelines. We performed our analyses at 3dpf. At this 
developmental stage, sex ratios cannot be determined (gonad differentiation begins around 
25dpf). Adult density was maintained at ~7-8 fish/L, and fish were fed twice daily with 
artemia and dry food (SDS-400, DIETEX France). Water temperature was maintained at 
28°C. 
 
Cell lines 
AB.9 (ATCC
 
CRL-2298) cells are fibroblast obtained from the caudal fin of an adult AB 
strain zebrafish. AB.9 cultures were grown in Leibovitz-L15 CO2-independent medium 
supplemented with 15% heat-inactivated bovine serum at 28°C and passaged when reaching 
90% confluency (1-2 times/week). 
 
METHOD DETAILS 
 
Construction of pUbi-CD63-pHluorin  
pUbi-CD63-pHluorin was constructed by first cloning CD63-pHluorin (human CD63; 
sequence identical to Verweij et al., 2018) using primer pairs 5'-
GGGGACAAGTTTGTACAAAAAAGCAGGCTGGatggcggtggaaggagga-3’ (fwd) and 5'-
GGGGACCACTTTGTACAAGAAAGCTGGGTCctacatcacctcgtagccacttct-3' (rev) into 
pDONR221 (Gateway, Invitrogen). pDONR221-CD63-pHluorin was subsequently 
recombined with p5E-ubi (Addgene plasmid # 27320), p3E-polyA 153, and pDEST R4-R3 
(Gateway, Invitrogen) to create pUbi-CD63-pHluorin.  
 
Morpholino injection 
The MO against zSyntenin-A, and Standard Control oligo were purchased from GeneTools, 
used at 1:4 dilution from a 1 mM stock, and injected at 0.5-1.0 nL. The Synt-a MO has been 
previously validated for its effect on the YSL (Lambaerts et al., 2012). To minimize potential 
off-targets effects in the current study, the optimal MO concentration for YSL-injection was 
titrated as the minimal concentration causing the studied phenotype while minimizing 
mortality or phenotypic abnormalities compared to control.  
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Plasmid DNA injections 
To induce expression of CD63-pHluorin, embryos were injected at the one-cell stage (for 
ubiquitous expression) or at 4h in the YSL (for YSL-specific expression). On the next day, 
injected embryos were inspected under a stereomicroscope. Only embryos that developed 
normally were assayed. 
 
VLDL labelling 
BODIPY C12 was dissolved in canola oil as lipid (slow release) carrier at 1.5 μg/μl; 
approximately 5nl was injected in the yolk per embryo.  
 
Decreasing pace-maker activity 
Lidocaine was dissolved in ethanol and used at 640µM. After 2h incubation, zebrafish pace-
maker activity was assessed by recording the heart-beat for 20 seconds at high speed (30Hz) 
using a video microscope with stage incubator maintained at 28°C.  
 
Live fluorescent imaging  
Embryos were anesthetized with tricaine and embedded in 1.5% low melting point agarose. 
For most experiments, embryos were imaged at 3dpf. Recordings were performed at 28°C 
using a Nikon TSi spinning-wide (Yokagawa CSU-W1) microscope, equipped with a 60x CFI 
Plan Apo IR SR W NA 1.27, a sCMOS 1200x1200 Prime95B from Photometrics (pixel 
size:11 µm) and a sCMOS 2048x2048 Orca Flash 4 v2 from Hamamatsu (pixel size:6.5 µm). 
 
DIC video-microscopy / ‘Nomarski’ 
Embryos were examined with a Reichert Polyvar 2 microscope with DIC optics and equipped 
with a Hitachi HV-C20 tri-CCD camera. All contrast-dampening functions were set off, so 
that with the ×100 (oil immersion) objective, the final magnification on a 26-cm video screen 
was ×4000 with excellent contrast, such that mitochondria and intracellular vesicle trafficking 
could be observed. Video-sequences were recorded from the Y/C output of the camera by a 
Sony DHR1000 tape recorder in Digital Video (DV) format. Single video images were 
captured and stored on a PC from the DV videotapes, through the Sony DVK2000 capture 
board. 
 
Electron microscopy 
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For conventional EM, Zebrafish embryos 3dpf were fixed in 2.5% glutaraldehyde in 0.1 M 
cacodylate buffer for 24 h, post-fixed with 1% osmium tetroxide, dehydrated in ethanol and 
embedded in epon as described (Raposo et al., 2001). Epon embedding was performed as 
described (Hurbain et al., 2008). Ultrathin sections of zebrafish were prepared with a Reichert 
UltracutS ultramicrotome (Leica Microsystems) and contrasted with uranyl acetate and lead 
citrate.  
For ultrathin cryosectioning and immunogold labeling, zebrafish were fixed in 2% PFA, 0.2% 
glutaraldehyde in 0.1M phosphate buffer pH 7.4. Zebrafishes were processed for 
ultracryomicrotomy and immunogold labeled using PAG 10 as described (Raposo et al., 
2001). 
Exosome pellets were deposited on carbonated grids and fixed in 2% PFA in 0.1 M phosphate 
buffer, pH 7.4. The grids were then processed for single immunogold labeled using PAG10 
(Raposo et al 2011) and embedded in methyl-cellulose Uranyl Acetate 0,4%. 
All samples were examined with a FEI Tecnai Spirit electron microscope (FEI Company), 
and digital acquisitions were made with a numeric camera (Quemesa; Soft Imaging System).   
 
Image analysis 
All imaging data was analysed using ImageJ. Mander’s overlap coefficient was determined 
using the JACoP plugin. 
 
Generation of EV-heatmap in zebrafish embryo 
The heatmap was generated using Fiji and MATLAB software. After image acquisition, the 
particles (immobilized EVs at the endothelial walls) were identified after analyses of the z-
stacks with Fiji for each fish. The positions of these events were registered on a gray-level 
support image of a 3dpf zebra fish plexus by drawing dots at the position of the events. Next, 
all support images were put together in a z-stack, one layer corresponding to each fish. The 
next step was to read this support-image z-stack layer by layer with MATLAB, where the dots 
representing the particles were automatically detected with the function HoughCircles (Yuan-
Liang Tang, Department of Information Management, Chaoyang University of Technology, 
Taichung, Taiwan) using the Circular Hough Transform based algorithm, giving the 
coordinates of the detected dots as output. Gaussian spots were then created at these 
coordinates, with an amplitude of each spot equal to 1. A sum projection of the different 
layers was generated, after which a black and white mask created with the gray level support 
image was applied to this sum projection. The gaussian spot amplitudes of each layers were 
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summed to produce the heatmap. The areas of the sum projection where the gaussian spot 
amplitudes are higher corresponds to high density areas of events. To produce the final 
heatmap, a custom colormap, inspired by the jet colormap, was applied to the sum projection. 
The colormap goes from black (no event) to red (high density areas). 
 
Exosome preparation from in vitro cultured cells 
Exosomes were prepared from the supernatant of 24h cultured AB.9 cells as described before 
(Théry et al., 2006). Briefly, exosomes were purified from the cultured media with exosome-
free serum. Differential centrifugations at 500 x g (2 x 10 min) and 2,000 x g (2 x 15min) 
were carried out in a standard lab culture centrifuge using 50mL tubes. Subsequent steps were 
carried out in an ultracentrifuge, using polyallomer tubes listed above. The 10,000 x g (2 x 
30min) steps eliminated cellular debris and centrifugation at 100,000 x g (60 min) pelleted 
exosomes. The exosome pellet was washed once in a PBS, centrifuged at 100,000 x g for 1 h 
and re-suspended in 50-200 μL PBS, depending on the starting volume. 
 
Exosome isolation from zebrafish embryos 
50 zebrafish embryos 3dpf were anesthetized and with Collagenase I, used at a concentration 
200mg/mL in a total volume of 500μl. Sample was incubated at 29°C for 30-45 min under 
slow agitation on a heating block, while the sample was intermittently triturated with a sterile 
200μl tip, every 10 minutes until large clumps disappeared. EDTA was added to stop the 
Collagenase activity. The final volume was adjusted to 1mL, and transferred to 11 x 34 mm 
centrifuge tubes.  
Differential centrifugations at 500 g (2 x 10 min), 2,000 g (2 x 15min), 10,000g (2 x 30min) 
eliminated cellular debris and centrifugation at 100,000 g (60 min) pelleted exosomes. The 
exosome pellet was washed once in a PBS, centrifuged at 100,000 g for 1 h and re-suspended 
in 50-200 μL PBS, depending on the starting volume. 
 
NTA measurements 
For NTA measurements of EV-size and concentration, concentrated samples were pre-diluted 
2000x, and analyzed using a Nanosight (LM10). Samples were measured at 5 different 
positions in the chamber for 1 min each, with stage temperature control set at 27°C. The 
videos were then processed by the Nanosight software (NTA 3.2 Dev Build 3.2.16).  
 
Label-free Mass-spectrometry  
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Exosomes were purified by differential ultracentrifugation as described above, and followed 
(for YSL derived exosomes) by an IP for GFP using GFP-trap magnetic agarose beads 
(Chromotek). Pull-downs were performed in biological replicates (n = 3) under agitation 
overnight at 4°C.  
To characterize the exosome proteins, we qualitatively and quantitatively analyzed them by 
Orbitrap Fusion Tribrid mass spectrometry, by using a label free approach.  For exosome 
quantification, SDS/PAGE was used without separation as a clean-up step, and only one gel 
slice was excised otherwise proteins were separated on SDS/PAGE and four gel slices were 
excised. Subsequently, gel slices were washed and proteins were reduced with 10 mM DTT 
before alkylation with 55 mM iodoacetamide. After washing and shrinking the gel pieces with 
100% MeCN, we performed in-gel digestion using trypsin/LysC (Promega) overnight in 25 
mM NH4HCO3 at 30 °C. Peptide were then extracted using 60/35/5 MeCN/H2O/HCOOH 
and vacuum concentrated to dryness 
Samples were chromatographically separated using an RSLCnano system (Ultimate 3000, 
Thermo Scientific) coupled to an Orbitrap Fusion Tribrid mass spectrometer (Thermo 
Scientific). 
Peptides were loaded onto a C18 column (75-μm inner diameter × 2 cm; nanoViper Acclaim 
PepMapTM 100 or 300 µm x 5 mm PepMapTM 100, 5 µm, Thermo Scientific), separated 
and MS data acquired using Xcalibur software. Peptides separation was performed over a 
linear gradient of 100 min from 5% to 25% or 5% to 35% MeCN (75-μm inner diameter × 50 
cm; nanoViper C18, 2 μm or 5 µm, 100Å, Acclaim PepMapTM RSLC, Thermo Scientific). 
Full-scan MS was acquired in the Orbitrap analyzer with a resolution set to 120,000 and ions 
from each full scan were HCD fragmented and analyzed in the linear ion trap. 
For identification the data were searched against the UniProtKB Zebrafish database using 
Sequest through proteome discoverer. Enzyme specificity was set to trypsin and a maximum 
of two missed cleavage site were allowed. Oxidized methionine, N-terminal acetylation, and 
carbamidomethyl cysteine were set as variable modifications. Maximum allowed mass 
deviation was set to 10 ppm for monoisotopic precursor ions and 0.6 Da for MS/MS peaks. 
The resulting files were further processed using myProMS (Poullet et al., 2007). FDR 
calculation used Percolator and was set to 1%. The label free quantification was performed by 
peptide Extracted Ion Chromatograms (XICs) computed with MassChroQ version 1.2.1 
(Valot et al., 2011). Global MAD normalization was applied on the total signal to correct the 
XICs for each biological replicate. Protein ratios were computed as the geometrical mean of 
related peptides. To estimate ratio significance, a two-tailed t test was performed and p-values 
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were adjusted with a Benjamini–Hochberg FDR procedure with a control threshold set to 
0.05. Fold change-based GO enrichment analysis was performed as in Kowal et al. (Kowal et 
al., 2016). 
 
Analysis of growth in the CVP  
For height measurements, the longest distance through the z-stack was used, obtained by 
maximum projection in z and using a fixed point (second ISV from the right). For 
measurements of the (relative) surface area increase, likewise a maximum projection in z was 
used and compared over time. To measure proliferation, the number of nuclei were counted at 
different time points. As a slight mosaicism of the kdrl:nls-mKate2 line could not be fully 
excluded, we expressed proliferation relative to the control.  
 
QUANTIFICATION AND STATISTICAL ANALYSIS  
We performed statistical analysis (Student’s two-tailed t-test for significance) using GraphPad 
Prism version 6.0 (GraphPad software). Unpaired analysis was used unless specified 
otherwise. Data distribution was assumed to be normal but this was not formally tested. 
Sample sizes, statistical test and P values are indicated in the figures or figure legends.  
 
DATA AND SOFTWARE AVAILABILITY 
The mass spectrometry proteomics data have been deposited to the ProteomeXchange 
Consortium (Vizcaíno et al., 2014) via the PRIDE partner repository with the dataset 
identifier PXD011258. We have submitted all relevant data of our experiments to the EV-
TRACK knowledgebase (EV-TRACK ID: EV180009) (Van Deun et al., 2017). 
 
 
SUPPLEMENTARY MATERIAL LEGENDS 
 
Sup Movie 1 | Real-time video of A) [0:00] a blood vessel posterior to the head, B) [1:03] 
blood vessel in the gills and C) [1:56] in the brain of a 3dpf CD63-pHluorin ubiquitously 
expressing zebrafish embryo. Related to: Fig 2A-B 
 
Sup Movie 2 | Real-time video of the cardinal vein of a 3dpf CD63-pHluorin YSL expressing 
zebrafish embryo. Related to: Fig 3 
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Sup Movie 3 | A) [0:00] Time-lapse of the CVP area of a 3dpf Tg(kdrl:Hsa.HRAS-mCherry) 
zebrafish embryo expressing CD63-pHluorin in the YSL. B) [0:38] CVP area imaged at high-
speed in a zebrafish embryo expressing CD63-pHluorin in the YSL (combination of three 
consecutively acquired stacks). Related to: Fig 4 
 
Sup Movie 4 | Macrophages in the CVP of zebrafish embryos expressing CD63-pHluorin in 
the YSL. A) [0:00] Close-up of CVP and dorsal vein area in Tg(mpeg1:mCherryF) zebrafish 
embryo expressing CD63-pHluorin in the YSL B) [0:09] Close-up of a macrophage in the 
CVP area of a 3dpf Tg(kdrl:Hsa.HRAS-mCherry) zebrafish embryo expressing CD63-
pHluorin in the YSL. C) [0:24] Time-lapse of a macrophage in the CVP area of a 3dpf 
BODIPY-C12 injected zebrafish embryo expressing CD63-pHluorin in the YSL. Related to: 
Fig 4E-G 
 
Sup Movie 5 | A) [0:00] Real-time video of the cardinal vein of a 3dpf CD63-pHluorin YSL 
expressing zebrafish embryo. B) [0:15] 3D-reconstruction of the mid-trunk segment of 3dpf 
zebrafish embryos expressing CD63-pHluorin in the YSL and mCherry under the ubiquitous 
RPL5 promoter. C) [0:34] Time-lapse of the neural tube of 3dpf CD63-pHluorin YSL 
expressing zebrafish. Video play-back speed is half. D) [0:40] 3D-reconstruction of the mid-
trunk segment of 3dpf zebrafish embryos expressing CD63-pHluorin in the YSL and mCherry 
under the ubiquitous RPL5 promoter and treated with 200nM BafA for 2h. Related to: Fig 5 
 
Sup Movie 6 | YSL exosome accumulation in the cardinal vein. A) [0:00] Time-lapse of the 
cardinal vein of a 3dpf Tg(kdrl:Hsa.HRAS-mCherry) zebrafish embryo expressing CD63-
pHluorin in the YSL, incubated for 45min with 100nM BafA prior to start of the time-lapse. 
B) [0:08] A z-stack and 3D-rendering of the cardinal vein of a 3dpf Tg(kdrl:Hsa.HRAS-
mCherry) zebrafish embryo expressing CD63-pHluorin in the YSL, incubated with 100nM 
BafA. Related to Fig 6. 
 
Sup Table I | Proteomic analysis on exosomes isolated from AB.9 caudal fibroblast cells. 
Related to figure 1.  
 
Sup Table II | Proteomics analysis on ex vivo isolated EVs from 3dpf zebrafish embryos – 
enrichment of proteins form YSL-derived EVs vs all EVs. Related to figure 3.  
 
 34 
 
ACKNOWLEDGEMENTS 
We acknowledge Vincent Fraisier, Ludovic Leconte, Laetitia Pidial and Christine Viaris for 
technical assistance and Karine Duroure and Mylène Lancino for assistance and helpful 
discussions. The authors greatly acknowledge the Cell and Tissue Imaging (PICT-IBiSA) and 
Nikon Imaging Centre, Institut Curie, member of the French National Research Infrastructure 
France-BioImaging (ANR10-INBS-04), the NeurImag imaging platform at the IPNP, and the 
Zebrafish Platform at Insitut Curie.  
 
AUTHOR CONTRIBUTIONS 
Conceptualization: F.J.V., G.V.N.; Methodology: F.J.V., G.V.N., F.D.B., M.P.; Validation: 
F.J.V.; Formal analysis: F.J.V., G.V.N., G.A., G.A.; Investigation: F.J.V., C.R., F.D., G.F., 
G.V.N.; Resources: F.D.B., P.H., J.G., P.Z.; Data Curation: F.J.V., G.A.; Writing - Original 
Draft: F.J.V., G.V.N.; Writing - Review & Editing: F.J.V., G.V.N., M.D.P., G.R., P.H., 
F.D.B., C.R., J.G.; Visualization: F.J.V.; Supervision: G.V.N., F.D.B., D.L.; Project 
administration: G.V.N.; Funding acquisition: F.J.V., G.V.N. 
DECLARATION OF INTERESTS 
The authors declare no competing interests. 
 
FINANCIAL SUPPORT 
Financing support from Fondation pour la Recherche Medicale (contract AJE20160635884), 
to G.v.N., the European Molecular Biology Organization grant (EMBO ALTF 1383-2014), to 
F.V., the Fondation ARC pour la Recherche sur le Cancer fellowship (PJA 20161204808), to 
F.V., LabEx CelTisPhyBio to G.v.N. and F.V., and a “Région Ile-de-France” grant to D.L. 
 
 
 
 
 
 
 
 
 
 
 35 
 
 
 
 36 
 
 
 
 37 
 
 
 
 38 
 
 
 
 39 
 
 
 
 40 
 
 
 
 41 
 
 
 
 42 
 
 
 
 43 
 
 
 
